New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2013
19:25 EDTELNRoyalty Pharma urges Elan shareholders to vote against proposals
Royalty Pharma posted a new investor presentation summarizing its Further Increased Offer for Elan Corporation and urging Elan shareholders to vote against all four of Elan's proposals at its upcoming Extraordinary General Meeting on June 17. Royalty believes the Further Increased Offer represents compelling, immediate value in the form of $13.00 in cash, plus continued upside participation through a contingent value right worth up to $2.50 per share, potentially valuing each Elan share at up to $15.50.
News For ELN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ELN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use